These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

524 related items for PubMed ID: 16258100

  • 1. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study.
    Fan HG, Houédé-Tchen N, Yi QL, Chemerynsky I, Downie FP, Sabate K, Tannock IF.
    J Clin Oncol; 2005 Nov 01; 23(31):8025-32. PubMed ID: 16258100
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
    Mehnert A, Scherwath A, Schirmer L, Schleimer B, Petersen C, Schulz-Kindermann F, Zander AR, Koch U.
    Patient Educ Couns; 2007 Apr 01; 66(1):108-18. PubMed ID: 17320337
    [Abstract] [Full Text] [Related]

  • 5. Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment.
    Collins B, Mackenzie J, Stewart A, Bielajew C, Verma S.
    Psychooncology; 2009 Feb 01; 18(2):134-43. PubMed ID: 18551510
    [Abstract] [Full Text] [Related]

  • 6. Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study.
    Hermelink K, Henschel V, Untch M, Bauerfeind I, Lux MP, Munzel K.
    Cancer; 2008 Nov 01; 113(9):2431-9. PubMed ID: 18823033
    [Abstract] [Full Text] [Related]

  • 7. The influence of erythropoietin on cognitive function in women following chemotherapy for breast cancer.
    Fan HG, Park A, Xu W, Yi QL, Braganza S, Chang J, Couture F, Tannock IF.
    Psychooncology; 2009 Feb 01; 18(2):156-61. PubMed ID: 18561284
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Impact of androgen deprivation therapy on physical and cognitive function, as well as quality of life of patients with nonmetastatic prostate cancer.
    Joly F, Alibhai SM, Galica J, Park A, Yi QL, Wagner L, Tannock IF.
    J Urol; 2006 Dec 01; 176(6 Pt 1):2443-7. PubMed ID: 17085125
    [Abstract] [Full Text] [Related]

  • 13. Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study.
    Collins B, Mackenzie J, Stewart A, Bielajew C, Verma S.
    Psychooncology; 2009 Aug 01; 18(8):811-21. PubMed ID: 19085975
    [Abstract] [Full Text] [Related]

  • 14. Does cognitive impairment after chemotherapy for breast cancer improve over time or does practice make perfect?
    Schagen SB, van Dam FS.
    J Clin Oncol; 2006 Nov 10; 24(32):5170-1; author reply 5171-2. PubMed ID: 17093282
    [No Abstract] [Full Text] [Related]

  • 15. Randomized controlled trial of an educational intervention for managing fatigue in women receiving adjuvant chemotherapy for early-stage breast cancer.
    Yates P, Aranda S, Hargraves M, Mirolo B, Clavarino A, McLachlan S, Skerman H.
    J Clin Oncol; 2005 Sep 01; 23(25):6027-36. PubMed ID: 16135471
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prospective study of long-term impact of adjuvant high-dose and conventional-dose chemotherapy on health-related quality of life.
    Buijs C, Rodenhuis S, Seynaeve CM, van Hoesel QG, van der Wall E, Smit WJ, Nooij MA, Voest E, Hupperets P, TenVergert EM, van Tinteren H, Willemse PH, Mourits MJ, Aaronson NK, Post WJ, de Vries EG.
    J Clin Oncol; 2007 Dec 01; 25(34):5403-9. PubMed ID: 18048822
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII.
    Bernhard J, Zahrieh D, Castiglione-Gertsch M, Hürny C, Gelber RD, Forbes JF, Murray E, Collins J, Aebi S, Thürlimann B, Price KN, Goldhirsch A, Coates AS, International Breast Cancer Study Group Trial VIII.
    J Clin Oncol; 2007 Jan 20; 25(3):263-70. PubMed ID: 17159194
    [Abstract] [Full Text] [Related]

  • 20. Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide.
    Jansen CE, Dodd MJ, Miaskowski CA, Dowling GA, Kramer J.
    Psychooncology; 2008 Dec 20; 17(12):1189-95. PubMed ID: 18506671
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.